Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07181551

Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the feasibility, acceptability, and preliminary efficacy of "Forward to Quit" (F2Q), a person-centered mobile health (mHealth) smoking cessation intervention designed specifically for transgender adults. The intervention was developed in collaboration with transgender individuals and gender-affirming healthcare providers. The study includes usability testing and a remote single-arm pilot trial. Primary outcomes include feasibility and acceptability of both the intervention and remote biochemical verification of smoking cessation. Secondary outcomes include self-reported and biochemically verified smoking cessation, as well as changes in psychosocial factors such as social support and gender affirmation. The goal is to inform a future large-scale trial and address tobacco-related health disparities in transgender populations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALForward to Quit (F2Q)A mobile health (mHealth) smoking cessation intervention designed specifically for transgender adults. Delivered via a secure website accessible by smartphone or tablet.

Timeline

Start date
2025-10-14
Primary completion
2030-12-01
Completion
2031-12-01
First posted
2025-09-18
Last updated
2026-03-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07181551. Inclusion in this directory is not an endorsement.

Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults (NCT07181551) · Clinical Trials Directory